Bendroflumethiazide

Chemical formula: C₁₅H₁₄F₃N₃O₄S₂  Molecular mass: 421.415 g/mol  PubChem compound: 2315

Therapeutic indications

Bendroflumethiazide is indicated for:

Used as the sole antihypertensive agent

Population group: only adults (18 years old or older)

Bendroflumethiazide produces a moderate but usefully prolonged fall of blood pressure in hypertensive patients. It may be used as the sole antihypertensive agent, or, as an adjunct to other drugs whose action it potentiates. In non-oedematous patients, there may be little noticeable diuretic effect.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Bendroflumethiazide is contraindicated in the following cases:

Bendroflumethiazide contraindications

at least one of
Hepatic insufficiency
Renal failure
Primary adrenocortical insufficiency
Peptic ulcer

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2019: BENDROFLUMETHIAZIDE Tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈